Which uterotonic agent is commonly used in the active management of the third stage of labor?

Oxytocin is widely recognized as the standard uterotonic agent utilized in the active management of the third stage of labor. The primary purpose of this intervention is to prevent postpartum hemorrhage by promoting uterine contractions immediately following delivery. Oxytocin works by stimulating the uterine muscles, thus facilitating the expulsion of the placenta and reducing the risk of excessive bleeding.

In the context of active management, oxytocin is typically administered intravenously or intramuscularly right after the birth of the baby, helping to establish effective uterine tone promptly. This practice is supported by current guidelines and evidence-based protocols, which emphasize the importance of timely intervention for enhancing maternal safety in the immediate postpartum period.

While other uterotonics like misoprostol, ergometrine, and carboprost also play roles in postpartum care, they are not the first-line choice for active management of the third stage of labor. Misoprostol may be used in specific settings or for patients who cannot receive oxytocin, ergometrine has contraindications in certain situations, and carboprost is generally reserved for cases of severe hemorrhage due to its additional side effects. This establishes oxytocin as the most commonly utilized and effective option in the active management of